CLGEX
Price
$59.43
Change
-$3.52 (-5.59%)
Updated
Apr 3 closing price
Net Assets
5.37B
GFACX
Price
$57.16
Change
-$3.41 (-5.63%)
Updated
Apr 3 closing price
Net Assets
279.82B
Ad is loading...

CLGEX vs GFACX

Header iconCLGEX vs GFACX Comparison
Open Charts CLGEX vs GFACXBanner chart's image
Columbia Large Cap Growth E
Price$59.43
Change-$3.52 (-5.59%)
VolumeN/A
Net Assets5.37B
American Funds Growth Fund of Amer C
Price$57.16
Change-$3.41 (-5.63%)
VolumeN/A
Net Assets279.82B
CLGEX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CLGEX vs. GFACX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLGEX is a Hold and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 280B vs. CLGEX (5.37B). CLGEX (0.00) and GFACX (0.00) have matching dividends . CLGEX was incepted earlier than GFACX: CLGEX (19 years) vs GFACX (24 years). GFACX (1.36) is less costly to investors than CLGEX (1.27). CLGEX is a more actively managed with annual turnover of: 39.00 vs. GFACX (25.00). CLGEX has a lower initial minimum investment than GFACX: CLGEX (0) vs GFACX (250). CLGEX annual gain was more profitable for investors over the last year : 1.84 vs. GFACX (-1.75). CLGEX return over 5 years is better than : 72.89 vs. GFACX (59.73).
CLGEXGFACXCLGEX / GFACX
Total Expense Ratio1.271.3693%
Annual Report Gross Expense Ratio1.271.3693%
Fund Existence19 years24 years-
Gain YTD-9.464-5.003189%
Front Load5%N/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets5.37B280B2%
Annual Yield % from dividends0.000.00-
Returns for 1 year1.84-1.75-105%
Returns for 3 years13.320.632,110%
Returns for 5 years72.8959.73122%
Returns for 10 years73.9744.46166%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLY9.54-0.41
-4.12%
Oatly Group AB
INDP0.47-0.03
-5.24%
Indaptus Therapeutics
VTRS8.16-0.50
-5.77%
Viatris
GDRX4.29-0.28
-6.13%
GoodRx Holdings
KOD2.40-0.27
-10.11%
Kodiak Sciences